Using this method, we observed an increase in CD147 glycosylation in response to HG (2.2 folds p < 0.001) and CML (4.9 folds, p < 0.000) treatments (Figure 2D). Here, BSG is linked to chronic myelogenous leukemia, BCR-ABL1 positive.